Publication:
The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.

dc.contributor.authorSánchez-Molina, Sara
dc.contributor.authorOliva-Martinez, Jose Luis
dc.contributor.authorGarcia-Vargas, Susana
dc.contributor.authorValls, Ester
dc.contributor.authorRojas-Cabañeros, Jose Maria
dc.contributor.authorMartínez-Balbás, Marian A
dc.contributor.funderMinisterio de Educación y Ciencia (España)
dc.contributor.funderGovernment of Catalonia (España)
dc.date.accessioned2025-01-24T12:57:33Z
dc.date.available2025-01-24T12:57:33Z
dc.date.issued2006-09-01
dc.description.abstractThe CBP [CREB (cAMP-response-element-binding protein)-binding protein]/p300 acetyltransferases function as transcriptional co-activators and play critical roles in cell differentiation and proliferation. Accumulating evidence shows that alterations of the CBP/p300 protein levels are linked to human tumours. In the present study, we show that the levels of the CBP/p300 co-activators are decreased dramatically by continuous PDGF (platelet-derived growth factor) and Ras signalling pathway activation in NIH 3T3 fibroblasts. This effect occurs by reducing the expression levels of the CBP/p300 genes. In addition, CBP and p300 are degraded by the 26 S proteasome pathway leading to an overall decrease in the levels of the CBP/p300 proteins. Furthermore, we provide evidence that Mdm2 (murine double minute 2), in the presence of active H-Ras or N-Ras, induces CBP/p300 degradation in NIH 3T3 cells. These findings support a novel mechanism for modulating other signalling transduction pathways that require these common co-activators.
dc.description.peerreviewed
dc.description.sponsorshipThis work was supported by grants to M. A. M.-B. from the Ministerio de Educación y Ciencia (SAF2002-00741 and PAMNBMB) and to J. M. R. (SAF2003-02604). S. S.-M. is the recipient of a fellowship from the Generalitat de Catalunya.
dc.format.number2
dc.format.page215-24
dc.format.volume398
dc.identifier.citationSánchez-Molina S, Oliva JL, García-Vargas S, Valls E, Rojas JM, Martínez-Balbás MA. The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway. Biochem J. 2006 Sep 1;398(2):215-24.
dc.identifier.doi10.1042/BJ20060052
dc.identifier.e-issn1470-8728
dc.identifier.issn0264-6021
dc.identifier.journalThe Biochemical journal
dc.identifier.otherhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1550303/
dc.identifier.pubmedID16704373
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26127
dc.language.isoeng
dc.publisherPortland Press
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2002-00741
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2003-02604
dc.relation.publisherversionhttps://doi.org/10.1042/BJ20060052
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAcetylation
dc.subjectcAMP-response-element-binding-protein-binding protein/p300 (CBP/p300)
dc.subjectHistone acetyltransferase activity (HAT activity)
dc.subjectMurine double minute 2 (Mdm2)
dc.subjectNIH 3T3 cell
dc.subjectRas pathway
dc.subject.meshAnimals
dc.subject.meshCell Cycle Proteins
dc.subject.meshEnzyme Activation
dc.subject.meshGene Expression
dc.subject.meshHistone Acetyltransferases
dc.subject.meshMice
dc.subject.meshNIH 3T3 Cells
dc.subject.meshPlatelet-Derived Growth Factor
dc.subject.meshProteasome Endopeptidase Complex
dc.subject.meshProto-Oncogene Proteins c-mdm2
dc.subject.meshSignal Transduction
dc.subject.meshTranscription Factors
dc.subject.meshUbiquitins
dc.subject.meshValine
dc.subject.meshp300-CBP Transcription Factors
dc.subject.meshras Proteins
dc.titleThe histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication57083f41-4350-4093-b25f-fd3390a2130c
relation.isAuthorOfPublicationeafdc372-b117-4dc2-a4c9-d22d1b111b9c
relation.isAuthorOfPublication370c9d7e-71b3-4b96-87ba-fe32e580397d
relation.isAuthorOfPublication.latestForDiscovery57083f41-4350-4093-b25f-fd3390a2130c
relation.isFunderOfPublicationc55dd540-f82b-4c19-8bde-4a91a6d53bde
relation.isFunderOfPublicationc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isFunderOfPublication.latestForDiscoveryc55dd540-f82b-4c19-8bde-4a91a6d53bde
relation.isPublisherOfPublicationf012329c-35f9-4fd5-9829-9cbe7db9f88d
relation.isPublisherOfPublication.latestForDiscoveryf012329c-35f9-4fd5-9829-9cbe7db9f88d

Files